Botulinum Toxin in Migraine Treatment

Simple item page
dc.contributor.authorAydinlar, Elif Ilgaz
dc.contributor.authorDikmen, Pinar Yalinay
dc.contributor.authorKocaman, Ayse Sagduyu
dc.date.accessioned2023-02-21T12:32:23Z
dc.date.available2023-02-21T12:32:23Z
dc.date.issued2013-01-01
dc.description.abstractSince botulinum toxin might have a therapeutic effect on pain, many studies investigating the efficiency of botulinum toxin in headache treatment have been done. The most satisfying results were achieved by botulinum toxin type A (BoNT/A) in the treatment of chronic migraine. In this paper, we reviewed the clinical effectiveness of BoNT/A in migraine and included our clinical experience. In our ongoing pilot study, where we have repeated BoNT/A injections every 12 weeks, The difference in the Migraine Disability Assessment (MIDAS) scores between the first and the second injections was 61.1\%
dc.description.abstractand between the first and the 3rd injections was found to be 65.72\%.
dc.description.issue1
dc.description.pages36-40
dc.description.volume50
dc.identifier.doi10.4274/npa.y7198
dc.identifier.urihttps://hdl.handle.net/11443/1038
dc.identifier.urihttp://dx.doi.org/10.4274/npa.y7198
dc.identifier.wosWOS:000323550400007
dc.publisherTURKISH NEUROPSYCHIATRY ASSOC-TURK NOROPSIKIYATRI DERNEGI
dc.relation.ispartofNOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
dc.subjectBotulinum toxin
dc.subjectchronic migraine
dc.subjectheadache
dc.titleBotulinum Toxin in Migraine Treatment
dc.typeArticle

Files

Collections

WOS